Enteric fever: Difference between revisions
From IDWiki
No edit summary |
m (→) |
||
Line 38: | Line 38: | ||
==Diagnosis== |
==Diagnosis== |
||
*Blood cultures (large volume, like x4), stool cultures, bone marrow |
*Blood cultures (large volume, like x4), stool cultures, bone marrow biopsy (most sensitive) |
||
*Biopsy (most sensitive) |
|||
==Management== |
==Management== |
Revision as of 14:19, 13 May 2024
Background
Microbiology
- Caused by Salmonella enterica subspecies enterica serotypes Typhi and Paratyphi
- Virulence is related to Vi antigen and invasin protein
Epidemiology
- Fecal-oral transmission acquired from contaminated food, milk, or water
- Less than 5% of infected people become chronic carriers, with bacteria remaining in the gallbladder despite adequate antibiotic treatment
Pathophysiology
- Induction of pH-shock proteins and other adaptions allow ingested bacteria to pass through the stomach and into the small intestine
- There, they penetrate the intestinal mucosa followed by mononuclear cells, which transport them to lymph nodes
- They multiple within the reticuloendothelial system during the incubation period
- After a threshold is reached, they disseminate to blood
Clinical Manifestations
- Most commonly presents as fever in the returned traveller
- Incubation period 5 to 21 days
- Symptoms progress over weeks
- First week: fever, chills, bacteremia, relative bradycardia, headache
- Second week: abdominal pain, and a blanchable papular rash ("rose spots") may appear
- Third week: can progress to gastrointestinal perforation, hepatosplenomegaly, GI bleed, secondary bacteremia
- Constipation is more common in adults, while diarrhea is more common in children and people with HIV
- CBC shows leukopenia and anemia
- Extraintestinal manifestations are myriad
Diagnosis
- Blood cultures (large volume, like x4), stool cultures, bone marrow biopsy (most sensitive)
Management
- Treatment with third-generation cephalosporins like ceftriaxone, stepped down to oral when improving and susceptibility data are available
- Alternatives are azithromycin, followed by ampicillin, TMP-SMX, chloramphenicol
- Avoid fluoroquinolones due to high resistance rate
- Duration 10 to 14 days
- Can take 4 to 6 days to defervesce, even with treatment
- Monitor for relapse 2 to 3 weeks after treatment ends